06 Jan 2021
The Cell and Gene Therapy Catapult (CGT Catapult) and Hertfordshire Local Enterprise Partnership (LEP) announce today that a new cell and gene therapy integration laboratory at the CGT Catapult facility in Stevenage will be part-funded by the Government’s Getting Building Fund.
The new laboratory will be exclusively dedicated to the provision of cell and gene therapy manufacturing training and will utilise both digital and established teaching platforms. Learners will be trained using state-of-the-art equipment capable of large-scale manufacture to meet the need for skilled workers to help accelerate the scale-up of growing cell and gene therapy companies locally.
The laboratory supports the national drive for skills development within the cell and gene therapy industry, and complements existing skills initiatives coordinated by CGT Catapult, including the Advanced Therapies Skills Training Network (ATSTN) and the Advanced Therapies Apprenticeship Community (ATAC).
Paul Witcombe, Head of Enterprise and Innovation, Hertfordshire LEP, said:
“We are delighted to have secured further investment to support future advances in cell and gene therapies. Skills digitalisation is a key differentiator and is absolutely critical if the UK is to remain a global centre of excellence in this sector.”